Cooling Fabrics and Exercise Performance in Endurance Athletes

Sponsor
McGill University (Other)
Overall Status
Completed
CT.gov ID
NCT02016521
Collaborator
(none)
20
1
2
5.9
3.4

Study Details

Study Description

Brief Summary

In humans, the primary means of cooling the body during exercise is through the evaporation of sweat from the skin surface. Clothing represents a layer of insulation that hinders the evaporation of sweat from the surface of the skin. It follows that clothing that imposes the least amount of resistance to evaporative heat loss may prove beneficial to the thermoregulatory, physiological and perceptual response to exercise, particularly in elite endurance-trained athletes. Thus, the purpose on this study is to examine the influence of wearing a sportswear garment made of a fabric (100% nylon) with superior evaporative characteristics on detailed thermoregulatory, cardiorespiratory, metabolic and perceptual responses to maximal exercise testing at normal room temperature and relatively humidity in a group of 25 endurance-trained cyclists and triathletes aged 20-60 years. It is hypothesized that wearing a garment made of 100% nylon will improve exercise performance (e.g., exercise endurance time) and that this improvement will reflect improvements in thermoregulatory, cardiorespiratory, metabolic and perceptual responses to exercise. Athletes will be recruited via contact with coaches of the McGill University Cycling and Triathlon teams as well as through contact with coaches of competitive cycling and triathlon teams/training groups in the Montreal and surrounding area. Initial contact will consist of a thorough explanation of the study procedures and pre-screening for the inclusion/exclusion criteria prior to study consent by the Principal Investigator and/or his delegate, either in person or by telephone or email. Eligible participants will visit McGill's Clinical Exercise & Respiratory Physiology Laboratory on 3 separate occasions over a period of 10-14 days. Visit 1 will include a maximal incremental bicycle exercise test for familiarization purposes and to determine maximal power output (MPO). Visits 2 and 3 will include a constant-power-output bicycle exercise test at 85% MPO under one of two conditions, in randomized order: (1) while wearing a garment made of 100% polyester, i.e., placebo; and (2) while wearing a garment made of 100% nylon, i.e., cooling fabric. At rest and during exercise at visits 2 and 3, detailed assessments of core body temperature will be made using a temperature sensor placed into the esophagus, while skin temperature and other physiological and perceptual parameters will be measured using standard techniques.

Condition or Disease Intervention/Treatment Phase
  • Other: Cooling Fabric
  • Other: Placebo Garment
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
"Keep Cool": a Randomized Trial on the Effect of Wearing a Garment Made of Cooling Fabrics on Thermoregulatory, Cardiorespiratory, and Perceptual Responses to Exercise in Endurance-trained Athletes
Study Start Date :
Jan 1, 2014
Actual Primary Completion Date :
Jul 1, 2014
Actual Study Completion Date :
Jul 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cooling Fabric

Garment made of 100% nylon fabric consisting of long sleeved shirt and full trouser.

Other: Cooling Fabric
Garment made of 100% nylon and consisting of long sleeved shirt and full trouser.

Placebo Comparator: Placebo Garment

Garment made of 100% polyester consisting of long sleeved shirt and full trouser.

Other: Placebo Garment
Garment made of 100% polyester consisting of long sleeved shirt and full trouser

Outcome Measures

Primary Outcome Measures

  1. Exercise endurance time (EET) [Participants will be followed until all study visits are completed, an expected average of 2 weeks]

    Exercise endurance time (EET) will be defined as the duration of loaded pedalling during constant work rate cycle exercise testing at 85% of each participants maximum incremental power output (in watts).

  2. Esophageal temperature (in degrees Celsius) at isotime during exercise [Participants will be followed until all study visits are complete, an expected average of 2 weeks]

    Esophageal temperature, recorded using an esophageal thermistor and estimating core body temperature, averaged over the last 30-secs of the highest equivalent exercise time (isotime) achieved by a given subject during exercise under the two treatment periods.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or Female

  • Non-smoker

  • Aged 20-60 years

  • Competitive cyclist and/or triathlete competing at the regional, provincial, national and/or international level.

  • Maximal rate of oxygen uptake on incremental cycle exercise testing greater than or equal to 60 ml/kg/min.

  • Forced expiratory volume in 1 second greater than or equal to 80% predicted.

  • Forced expiratory volume in 1 second/forced vital capacity ratio greater than or equal to 70%.

  • Women: taking an oral contraceptive for at least 6 months prior to study enrolment.

Exclusion Criteria:
  • History or presence of cardiovascular, vascular, respiratory, renal, liver, musculoskeletal, endocrine, neuromuscular, metabolic, menstrual cycle and/or sleep related disease/disorder/dysfunction.

  • Inability to perform exercise and pulmonary function testing.

  • Taking doctor prescribed medication, other than oral contraceptives for women.

  • Allergy to lidocaine or its 'caine' derivatives.

Contacts and Locations

Locations

Site City State Country Postal Code
1 McGill University, Dept. of Kinesiology & Physical Education, Clinical Exercise & Respiratory Physiology Laboratory Montreal Quebec Canada H2W1S4

Sponsors and Collaborators

  • McGill University

Investigators

  • Principal Investigator: Dennis Jensen, Ph.D., McGill University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Dennis Jensen, Ph.D., Assistant Professor, McGill University
ClinicalTrials.gov Identifier:
NCT02016521
Other Study ID Numbers:
  • A00-M108-13A
First Posted:
Dec 20, 2013
Last Update Posted:
Aug 26, 2015
Last Verified:
Aug 1, 2015
Keywords provided by Dennis Jensen, Ph.D., Assistant Professor, McGill University

Study Results

No Results Posted as of Aug 26, 2015